2 incredible ASX shares to buy in November

This could be a great time to buy these investments.

| More on:
Blue light arrows pointing up, indicating a strong rising share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Pro Medicus Ltd, a leading healthcare informatics company, showcases impressive financials with a 74% EBIT margin and significant profit and revenue growth in FY25.
  • Despite a high P/E ratio, Pro Medicus continues to secure multi-year contracts, boosting future revenue prospects and offering robust investment potential.
  • The VanEck MSCI International Small Cos Quality ETF offers diversified exposure to high-ROE and low-leverage companies, averaging a 16% annual return over three years.

Owning the highest-quality ASX shares can deliver excellent returns because of the power of their brands, financials, market share and management.

Over the long-term, I'd expect a high-quality business to deliver more profit growth and share price growth compared to a mediocre company.

Of all of the options that Australians could choose for their portfolios, there are few options as high-quality as the ones below.

Pro Medicus Ltd (ASX: PME)

I believe Pro Medicus is one of, if not the, highest quality ASX shares. It describes itself as a leading healthcare informatics company. The company provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups worldwide

Pro Medicus has incredibly high profit margins. In FY25, the company generated revenue of $213 million and it produced net profit after tax (NPAT) of $115.2 million with $157.7 million of underlying operating profit (EBIT). Its underlying EBIT margin of 74% is incredible.

A very large amount of new revenue is turned into profit. FY25 saw 31.9% revenue growth and 39.2% net profit after tax (NPAT) growth, which has helped propel Pro Medicus' share price higher. It continues winning new multi-year contracts, which will translate into significantly larger revenue in the coming years.

It is also successful at renewing contracts at a higher fee rate, as well as selling additional modules to existing customers.

It may still trade on a high price/earnings (P/E) ratio, but it's lower now after falling by more than 20% since mid-July 2025.

According to the forecasts on CMC Markets, the ASX share is trading at 124x FY27's estimated earnings.

VanEck MSCI International Small Cos Quality ETF (ASX: QSML)

I think small companies have tremendous growth potential because they are usually much earlier on with their growth journeys – they can still significantly scale from where they are today.

But, investing in small businesses can come with risk, so I'd want to only own good ones. How do you pick out the best ones to own? The QSML ETF could be an excellent option for a few reasons.

The exchange-traded fund (ETF) implements a few quality screening tests to ensure it just invests in the best of the best.

The QSML ETF only invests in businesses with a high return on equity (ROE), good earnings stability and low financial leverage. In other words, these businesses make high levels of profit on retained shareholder money, profit is usually growing and debt levels are low.

It invests in 150 of these high-quality small companies from across the world, with different sectors represented in the portfolio, so it's a diversified investment. Pleasingly, over the last three years, it has returned an average of 16% per year. I think this could still be a great time to invest in these small global companies for the long-term.

Motley Fool contributor Tristan Harrison has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 unstoppable ASX shares to buy with $3,000

These businesses have strong futures.

Read more »

Man holding Australian dollar notes, symbolising dividends.
Dividend Investing

Want to build up passive income? These 2 ASX dividend shares are a buy!

These stocks are giving investors exciting payouts every year.

Read more »

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
Growth Shares

2 ASX shares to buy and hold for the next decade

These businesses have a lot of growth potential ahead…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Opinions

4 ASX shares I'd buy with $10,000 today

Here’s where I’d invest some spare cash right now.

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Gold

Why I think ASX 200 gold shares like Newmont and Northern Star will keep surging higher in 2026

After smashing the benchmark in 2025, I think Northern Star, Newmont and rival ASX 200 gold stocks will outperform again…

Read more »

A child dressed in army clothes looks through his binoculars with leaves and branches on his head.
Opinions

Up 735% in a year! The red-hot EOS share price is smashing Droneshield and other defence stocks

Investor interest in defence stocks has boomed.

Read more »

a uranium-fuelled mushroom shaped cloud explosion surrounded by a circle of rainbow light with a symbol of an atom to one side of it.
Opinions

What's next for the best-performing ASX 200 stock of 2025?

This ASX stock boomed in 2026.

Read more »